Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma.

Unni AM, Lockwood WW, Zejnullahu K, Lee-Lin SQ, Varmus H.

Elife. 2015 Jun 5;4:e06907. doi: 10.7554/eLife.06907.

PMID: 26047463

Rescuing US biomedical research from its systemic flaws.

Alberts B, Kirschner MW, Tilghman S, Varmus H.

Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5773-7. doi: 10.1073/pnas.1404402111. Epub 2014 Apr 14.

PMID: 24733905

Addressing the growing international challenge of cancer: a multinational perspective.

Varmus H, Kumar HS.

Sci Transl Med. 2013 Mar 6;5(175):175cm2. doi: 10.1126/scitranslmed.3005899.

PMID: 23467558

Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins.

Lockwood WW, Zejnullahu K, Bradner JE, Varmus H.

Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19408-13. doi: 10.1073/pnas.1216363109. Epub 2012 Nov 5.

PMID: 23129625

Three decades of Wnts: a personal perspective on how a scientific field developed.

Nusse R, Varmus H.

EMBO J. 2012 Jun 13;31(12):2670-84. doi: 10.1038/emboj.2012.146. Epub 2012 May 22. Review.

PMID: 22617420

Science funding: Provocative questions in cancer research.

Varmus H, Harlow E.

Nature. 2012 Jan 25;481(7382):436-7. doi: 10.1038/481436a. No abstract available. 

PMID: 22281578

The Art and Politics of Science.

Varmus H.

New York: W.W. Norton & Company; 2009.

PMID: 24696889